На главную
Результаты поиска “Pharmaceutical cost control generic drugs” за 2011
Conversation about drug pricing | Health care system | Heatlh & Medicine | Khan Academy
 
13:33
Dr. Laurence Baker talks to Sal about how drug prices are set. Created by Sal Khan. Watch the next lesson: https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/health-care-costs-in-us-vs-europe?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Missed the previous lesson? https://www.khanacademy.org/science/health-and-medicine/health-care-system/v/blue-cross-and-blue-shield?utm_source=YT&utm_medium=Desc&utm_campaign=healthandmedicine Health & Medicine on Khan Academy: No organ quite symbolizes love like the heart. One reason may be that your heart helps you live, by moving ~5 liters (1.3 gallons) of blood through almost 100,000 kilometers (62,000 miles) of blood vessels every single minute! It has to do this all day, everyday, without ever taking a vacation! Now that is true love. Learn about how the heart works, how blood flows through the heart, where the blood goes after it leaves the heart, and what your heart is doing when it makes the sound “Lub Dub.” About Khan Academy: Khan Academy is a nonprofit with a mission to provide a free, world-class education for anyone, anywhere. We believe learners of all ages should have unlimited access to free educational content they can master at their own pace. We use intelligent software, deep data analytics and intuitive user interfaces to help students and teachers around the world. Our resources cover preschool through early college education, including math, biology, chemistry, physics, economics, finance, history, grammar and more. We offer free personalized SAT test prep in partnership with the test developer, the College Board. Khan Academy has been translated into dozens of languages, and 100 million people use our platform worldwide every year. For more information, visit www.khanacademy.org, join us on Facebook or follow us on Twitter at @khanacademy. And remember, you can learn anything. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s Health & Medicine channel: https://www.youtube.com/channel/UC1RAowgA3q8Gl7exSWJuDEw?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 50024 Khan Academy
Prescription Drug Costs Going Up
 
02:26
The price of prescription drugs is skyrocketing. According to the U.S. Government Accountability Office, last year, the price index for the top 100 commonly used drugs has gone up 6.6 percent over the past five years.
Просмотров: 330 FOX 2 St. Louis
Development and Delivery of Pharmaceutical Products  (CMC) - MaRS Best Practices
 
01:07:46
Moving from drug discovery to drug development requires a particular skillset usually not yet honed by start-ups. This phase of the development process is highly regulated and critical. Let Dr. Colin Minchom take you through the aspects of the Chemistry, Manufacturing and Control (CMC) portion of the drug development process. Watch this video to learn about the pharmaceutical product development which includes objectives of formulation, cost-effective strategies to reach key milestones and more. MaRS -- Building Canada's next generation of global technology companies. marsdd.com
Просмотров: 25728 MaRS Entrepreneurship Programs
The Future Of Generics
 
03:31
Mylan President, Heather Bresch, says the generic drug market will continue to be a winner.
Просмотров: 2360 Forbes
What if: A sliding scale were used to reimburse generic drugs to effectively drive down prices?
 
07:36
The policy option presented here was chosen to stimulate discussion, but is only one of several options examined by the author in the report "Managing Pharmaceutical Expenditure: An Overview and Options for Canada". Presenter and author: Aidan Hollis, Department of Economics, University of Calgary This is one in a series that puts forward tangible policy options for addressing the sustainability of Canada's healthcare. The series presents possibilities and opportunities for improving efficiency and providing additional revenue. On July 10, 2011, these options were presented to an international audience gathered in Toronto for the annual iHEA conference. They were selected by the presenters themselves, who are also authors of knowledge syntheses about healthcare financing that were commissioned by CHSRF (many other options are presented in their syntheses, which you will also find here). More at www.chsrf.ca
Просмотров: 641 CHSRF Legacy
Pharmocracy - How Much are Americans Overpaying for Prescription Drugs?
 
02:04
http://lef.org/pharmocracy This eye-opening video exposes the inefficient and corrupt reasons why medical prices have skyrocketed out of control. More important, it provides a blueprint for what citizens can do to combat the regulatory stranglehold over health care that enables the medical establishment to defraud consumers out of their health and money.
Просмотров: 361 Life Extension
Pharmacy Business Plan Outline
 
03:15
http://www.freebptemplate.com - pharmacy business plan outline
Просмотров: 23044 oneplanner
Emergency Contraceptive Pills
 
03:04
Emergency Contraceptive Pills also called as morning-after pill or ECs or Post Coital Pills, they are the tablets taken after unprotected intercourse, we have explained all facts related to ECs, when to take, what is the dose that need to be taken? When to avoid emergency contraceptive pills. We have also told by which trade names of emergency contraceptive pills are available in India.
Просмотров: 590013 Dr. Vikram
Prescription Drugs and Their Effects
 
07:44
This video is part of an educational series on Prescription Drug Disorders produced by the Center for Interventions, Treatment & Addictions Research (CITAR) at the Wright State University Boonshoft School of Medicine. The series was produced to meet an educational objective under a contract from Public Health — Dayton and Montgomery County (PHDMC). This project was funded, in part, by the Preventive Health and Health Services Block Grant from the Centers for Disease Control and Prevention (CDC) and administered by the Ohio Department of Health (ODH). The contents of the series are solely the responsibility of the presenters and do not necessarily represent the official views of the CDC, ODH, PHDMC or Wright State University. The series was created and developed by Russel Falck, M.A., associate professor of community health and PI of the project. Robert Carlson, Ph.D., professor of community health, is co-PI of the project and CITAR director. Raminta Daniulaityte, Ph.D., is research assistant professor of community health and a co-investigator on the project. Tim Lane, M.Ed., is the project's injury prevention coordinator. Videotaping and editing was provided by Wright State's Computing and Telecommunications Services. For more information, visit: http://www.med.wright.edu/rxdrugs/drugsandeffects
Просмотров: 375 Rx Drug Poisoning Project
Supreme Court to Hear Generic Drug Appeal [audio]
 
12:29
Nov. 8 (Bloomberg Law) -- The U.S. Supreme Court will hear the oral arguments in a case between Novo Nordisk A/S, the manufacturer of diabetes drug Prandin, and generic drug maker Caraco Pharmaceutical Laboratories, Ltd. The legal dispute, over the manufacture of a generic version of the drug, centers on interpretation of the Hatch-Waxman Act and could change how brand-name drug makers use patent law. Tony Dutra, legal editor of BNA's Patent, Trademark & Copyright Journal, talks with Bloomberg Law's Josh Block about the case which will be argued before the Court on Dec. 5. https://www.bloomberglaw.com Follow on Twitter: @BloombergLaw @JoshBlock560
Просмотров: 439 Bloomberg Law
Policy options to control drug spending
 
13:19
As part of the Canadian Health Services Research Foundation's stakeholder event series, University of Toronto professor, Paul Grootendorst presented his new report, co-authored with Aidan Hollis, to healthcare leaders in Ottawa on February 18, 2011. Listen to the talk about the state of drug spending in Canada and possible policy options that may both contain costs and encourage innovation.
Просмотров: 435 CHSRF Legacy
A Different Kind of Drug Dealer
 
04:08
Chris Johnson's MedSavers pharmacy helps uninsured patients access affordable medications.
Просмотров: 2485 McCombs School of Business
The High Cost of Medicine
 
03:18
A doctor explains why a patient doesn't need everything that's advertised on TV
Просмотров: 213 Habariyaku2
The economics of drugs
 
17:28
As part of the Canadian Health Services Research Foundation's stakeholder event series, University of Calgary professor, Aidan Hollis, presented to healthcare leaders in Ottawa on February 18, 2011. Listen to his discussion of the implications of policies around generic pricing, pharmacies, and competition, and possible roles for government to play in improvements.
Просмотров: 402 CHSRF Legacy
TV Company Uses Ads to Control Pharmaceutical Market
 
05:34
With the power of media as a leader, Televisa, Mexico's industry communications giant, is taking over the market of generic drugs. Watch more videos made by the VJ Movement reporters from around the world on http://www.vjmovement.com or subscribe to our Youtube channel.
Просмотров: 223 TheVJMovement
The Street Value Of Your Medicine Cabinet
 
03:45
In your kitchen or bathroom right now is one of the hottest drugs for addicts in Central Ohio.
Просмотров: 66229 NBC4 WCMH-TV Columbus
A true miracle- How I got rid of my acne. Daily skin-care routine.
 
12:37
Purchase the exact kit mentioned in video here: http://go.magik.ly/r/mamichula/d629/ (NOT SPONSORED) So the acne.org system worked great for my sister, Melanie...however I was not so lucky!!! :( Instead ACCUTANE is the only thing that cured me!!! See my youtube journery here: https://www.youtube.com/playlist?list=PLpGx5fmf3u7A5ncuWX85OAiziiE8XxzJw I FINALLY GOT A P.O. BOX!!!! MamiChula8153 (Lee) P.O. Box 154 East Islip, New York 11730-0154 Please send me letters, postcards, pictures!!! I don't want any of you spending your hard earned money on me. I would love to get to know about YOU! Whether you just want to reach out, need advice, have questions...this is a very special way for me to connect with my viewers. Please specify on envelope if I can read on air or if you would prefer for me to keep it private! CANT WAIT TO HEAR FROM YOUUUUU!!!!!!! :) XOXO! Follow me on Instagram & Facebook!! Instagram: Official_MamiChula Facebook.com/MamiChula8153FanPage This video is in NO way sponsored. I am not being payed/compensated for my review, and I am no affiliated with any brands mentioned. I am not a dermatologist, what worked for my skin may not work for others, but if you ask me- it is definitely worth a try. HOW I GOT RID OF ACNE SCARRING AT HOME (With Before & After Pics!!) http://youtu.be/3YHpnj5iSpk I decided to film this video so I could help anyone out there that is going through what I have been through. Intense acne can truly take an emotional toll on a person, this skin care system has changed my life. TAGS how i cured my acne how to at home skin care remedy system acne.org zits pimples blemishes scars sensitive oily oilyness treatment cure miracle benzoyl peroxide cleanser treatment moisturizer flakey dry acne prone large pores redness hyperpigmentation for men women teens natural easy hormones accutane differin nutrition ugly nasty embarrased hide helpful tips dealing with clean clear blackheads whiteheads dermatologist laser complexion positive "Acne Vulgaris" health beauty diet food cosmetics hiding hide camoflauge treat heal long term makeup
Просмотров: 13450378 MamiChula8153
ONDCP Prescription Drug Plan
 
01:59
ONDCP announcement of the Office of National Drug Control Policy 2011 Prescription Drug Plan
Просмотров: 37 nopetaskforce
Drug Prices to Drop Thanks to Expiring Patents
 
01:45
Consumer Watchdog's Jerry Flanagan discusses the anticipated 20% - 80% reduction in price for several name-brand drugs whose patents will expire in the next few months.
Просмотров: 216 ConsumerWatchdog
Why was the Pharmaceutical Industry not affected by the global meltdown in 2008?
 
03:29
IIFM invited Mr. Mohan Seshadri, the GM & Head - Training & Development at Ranbaxy Ltd., for a Guest Lecture at the Mumbai campus. He explains how the global economic meltdown had little impact on the Pharmaceutical Industry. For more information please visit http://www.iifmglobal.com/media/corporate-speakers-at-campus.php
Просмотров: 284 IIFMglobal
What if: The entry of new pharmaceuticals was managed?
 
07:45
What if: The entry of new pharmaceuticals was managed and their prices were negotiated based on value for the country as a whole, by using existing health technology assessment capacity? The policy option presented here was chosen to stimulate discussion, but is only one of several options examined by the author in the report "Value-Based Pricing of Pharmaceuticals in Canada: Opportunities to Expand the Role of Health Technology Assessment" Presenter and author: Chris G. Cameron, Canadian Agency for Drugs and Technologies in Health (CADTH) This is one in a series that puts forward tangible policy options for addressing the sustainability of Canada's healthcare. The series presents possibilities and opportunities for improving efficiency and providing additional revenue. On July 10, 2011, these options were presented to an international audience gathered in Toronto for the annual iHEA conference. They were selected by the presenters themselves, who are also authors of knowledge syntheses about healthcare financing that were commissioned by CHSRF (many other options are presented in their syntheses, which you will also find here). More at www.chsrf.ca
Просмотров: 718 CHSRF Legacy
Health Care Inform: Simple Solutions to America's Overspending & Overmedicating
 
02:19
Health Care Inform is merely an idea & we need your help to make it happen. 1. Share on Facebook 2. Visit our website www.healthcareinform.org 3. "Like" it here on YouTube and on Facebook Are you concerned about deficit spending, the rising cost of healthcare or the overuse of prescription drugs? The time has come for the safer, cheaper drugs and remedies to have a voice! Health Care Inform is an innovative plan for a public health education campaign to promote inexpensive over-the counter medicines, generic prescription drugs, natural remedies and healthy lifestyles. Drug companies are successfully marketing the latest fashionable drugs (which are marginally safe and questionably effective), while the "tried and true" alternatives, which have been proven safe for decades, have no voice because of their low profit status. In a time of extensive deficit spending, there are millions of dollars to be saved (not to mention lives). Physicians and patients can be re-educated three ways: 1) by "reps" who visit doctors' offices 2) by publishing resources 3) by public service announcements.
Просмотров: 491 Pepperberries
re: The 1200% Increase in my Prescription Drug Costs
 
08:03
VYou:  http://vyou.com/tdcmoncton Facebook: tdcmoncton Twitter: tdcmoncton http://dailybooth.com/tdcmoncton/ Blogtv: http://www.blogtv.com/People/tdcmoncton Questions: http://www.formspring.me/tdcmoncton CanAmFun channel: http://www.youtube.com/user/canamfun http://www.stickam.com/member/tdcmoncton
Просмотров: 360 Cigare&Whiskey
Drug Shortages in America
 
05:07
WASHINGTON -- U.S. Senator Orrin Hatch (R-Utah), Ranking Member of the Senate Finance Committee, delivered the following opening statement at a committee hearing examining the impact of drug shortages in America: Chairman Baucus, thank you for convening today's hearing on such an important issue affecting our nation's patients and caregivers. We have all seen the disturbing stories in the press over the past several months about doctors unable to access critical medical products for their patients, and the impact that these drug shortages have had on patient care. While there is no doubt that increased attention and coordination has occurred between manufacturers and the government to begin addressing this problem, clearly more can be done to mitigate these shortages in the future. Drug supply shortages are not new. Any product that involves complex manufacturing and distribution could face some supply challenges. What is new is the volume of shortages, the importance of the therapies that are experiencing shortages, and the challenges these shortages present to patients and caregivers. Every year since 2005, drug shortages have become more prevalent and widespread. In 2009, there were 157 products on the FDA's shortage list, and in 2010 that number increased to 178. According to the University of Utah, which keeps track of shortages for the American Society of Health System Pharmacists, the total number of drugs in shortage currently exceeds 275 FDA- approved therapies and continues to grow. What is the impact of these increasing shortages? This crisis means worse outcomes for our patients, increased costs for caregivers and the government, slower medical advancement, and a persistent undermining of confidence in our country's healthcare system. Many of these drugs in shortage are used in current oncology treatment regimens. Not only are drug shortages impacting current treatments, they are harming future patients by delaying clinical trial results, increasing the length of clinical trials, and raising costs for research organizations. Our federal payer system is also bearing the cost of drug shortages. Clinicians are forced to scramble to find alternative treatment options for vulnerable patients, often at a much higher price for both the patient and the government. According to research by Premier, drug shortages could cost U.S. hospitals at least $415 million annually. This is because more expensive substitutes are often needed, intermediaries significantly mark up the price of these drugs, and there are additional labor costs associated with finding these alternative solutions. So what is causing this crisis? While this is clearly a complex issue, I believe we must look at the impact of federal programs on the generic injectable market. Seventy-four percent of drug shortages involved sterile injectables in 2010. I do not believe it is simply a coincidence that shortages are disproportionately impacting products with highly complex manufacturing processes that are also some of the lowest priced therapies. And I am not the only one to think that economic incentives play an important role in this issue. As recently highlighted in an article in the New England Journal of Medicine, experts contend that federal government pricing and rebate programs are a significant contributing factor to the current drug shortage crisis. The article also notes that there is an "untapped capacity" to produce generics but indicates that incentives to attract new entrants would be required to create redundancy in the market. Mr. Chairman I ask unanimous consent that this article be included in the record. Current pricing structures have been very effective at driving generic utilization. However, they may not fully capture or reward the costs associated with the complex development and manufacturing of injectables, as opposed to the more straightforward manufacturing process in the pill market. The current situation is simply unacceptable, and we must act to address this growing crisis. As most of my colleagues know, I am working on a solution that will continue to improve coordination between manufacturers and the government, but that also addresses some of the federal price control and rebate structures that prevent the true costs of bringing these important medicines to patients from being adequately addressed. I urge my colleagues to join me in working to solve this problem in the very near future. Senator Baucus, thank you again for convening this hearing today. I look forward to hearing from our witnesses and having a serious discussion about the steps we must take to address this crisis.
Просмотров: 337 SenatorOrrinHatch
Mylan announces Earnings
 
02:59
Heather Bresch, President of the pharmaceutical giant, on their recent announcement.
Просмотров: 1184 Forbes
New oxycontin more difficult to abuse?
 
01:28
For months, one of the most abused prescription drugs has been replaced by a new formulation, making it more difficult to abuse, but it may also be less effective for patients who need it the most.
Просмотров: 46127 ABC15 Arizona
Dr Oz's Recommendation on Vitamins
 
03:12
http://livingwholesome.com/index.php/category/vitamins Dr. Oz gives us a quick summary on what vitamin supplements he takes. Also, go to our blog to see our review on the best vitamin supplement brands! Here's his daily supplement regimen: 1. A one-a-day multi-vitamin with vitamins A,B,C,D, and E 2. Vitamin D-3 supplement (preferably with Calcium-Magnesium) 1,000 to 1,200 IU 3. Omega-3s (with DHA): Either Algae or Fish Oil based
Просмотров: 1172919 livingwholesome
The Real Truth About Birth Control Dangers
 
04:48
YAZ and Yasmin birth control pills and their generic offspring have made billions of dollars for pharmaceutical manufacturers advertising them not only for birth control, but as the antidote to acne and premenstrual problems. Tragically, thousands of young women have paid the price with lethal side effects ranging from blood clots to heart attacks, strokes, and sudden death.
Просмотров: 6963 Searcy Law Video
Acne medication Ro-accutane linked to medical student's suicide
 
05:58
A father's account of his medical student son's suicide he believes was caused by adverse reaction to acne drug Ro-accutane / isotretinoin. Generic versions of this drug include: Sotret, Claravis, Amnesteem. Roche have withdrawn Roaccutane/Accutane from sale and they deny this withdrawal is linked to costly litigation in the US, due to Inflammatory Bowel Disease believed to be caused by isotretinoin. This video and other personal accounts together with talks by Professor David Healy, Professor Heather Ashton, Dr Andrew Herxheimer at our conference can be viewed at http://vimeo.com/user1816628/videos In this video, Jon Medland, who bravely agreed to be interviewed at the APRIL charity conference in 2008, gives his moving account of the sequence of events, following his son's decision to take Roaccutane to deal with moderate acne on his back, is just one example of a suicide linked to adverse reaction (ADR) probably triggered by medication. In a recent review of Yellow Card reports of ADRs by patients overseen by Professor Anthony Avery of Nottingham University and 5 other universities, for which I was Chair of the Advisory Group: Reports of suicidal thoughts was the 11th most commonly reported adverse reaction, almost as common as reports of rashes reported as linked to several different medications. I recently attended the inquest of a young woman who has been prescribed Roaccuate plus Dianette (Diane-35) and Prozac (fluoxetine) and Zopiclone a sleeping pill. All drugs linked to side effects of suicidal thoughts, actions and completed suicide. The Coroner only focussed on one drug and chose to ignore the others, probably because he unaware to the risks of each one of the four drugs, let alone the lethal combination of taking them all together. There are shortly to be inquests for young women who took their own lives, one in Australia who's suicide was linked to Dianette also known as Diane-35 or cyproterone-acetate and ethinylestradiol. The other in the UK linked to psychiatric drugs given following a trip abroad when the young woman used anti-malaria drug Malarone. All antimalarials are linked to psychiatric ADRs. Read more about this problem on www.april.org.uk and join with APRIL in a campaign to include ' Medication induced suicide' in the Suicide Prevention Strategy for England which has excluded this cause of suicide since its inception. The email address to contact the Department of Health in Whitehall office dealing with the revised strategy is on the Home Page of www.april.org.uk More video films from our conference may be viewed at http://vimeo.com/user1816628/videos Please contact APRIL if you think you, a friend or family member have had a psychiatric ADR. info at april dot org dot uk
Просмотров: 2520 APRIL charity
Lack of Drugs Puts Ukraine's HIV Patients at Risk
 
02:43
For more news and videos visit ☛ http://english.ntdtv.com or Follow us on Twitter ☛ http://twitter.com/NTDTelevision Twenty-thousand HIV-positive patients in Ukraine may die if the Ukraine government does not buy necessary drugs. Five of the 17 drugs required by these patients are in short supply and doctors say interrupting treatment or substituting other drugs could have devastating consequences. More from our correspondent in Kyiv. 20,000 HIV-positive patients may die in Ukraine, due to a lack of medications and treatment. Of the 17 drugs required by these patients, Ukraine is now short of at least five. Ukraine's National HIV Support Network says that the Ministry of Health has delayed buying necessary medication. [Sergey Dmitriev, Ukrainian HIV Support Network]: "One man may soon die soon. One man will soon be in a serious situation -- he already has tuberculosis or pneumonia and he was denied treatment because there were no drugs." Doctors say that fifty percent of people infected with HIV could die within a year if they don't receive timely treatment. The Ministry of Health has acknowledged that some drugs are missing. According to an official statement, they say that patients are being given similar drugs. [Sergey Dmitriev, Ukrainian HIV Support Network]: "This is unacceptable under any circumstance. These are high-precision drugs -- it is not aspirin, it is not an anesthetic -- and the amount of drug that needs to be taken depends on body weight." However, the greatest danger in substituting drugs is that the virus in a patient may develop a resistance to the drug, making the treatment ineffective. Doctors in Ukraine do not routinely conduct resistance tests for each patient to check what drugs may be ineffective. [Sergey Dmitriev, Ukrainian HIV Support Network]: "Ukraine could become exposed to a certain virus, as a result of resistance, for which there are no treatment options." The delay in providing drugs also means that treatment could be completely stopped for a few days, which could lead to disastrous consequences. [Tatiana Stepchenkova, Physician-Virologist]: "Can you imagine -- we have kept the virus under control and not let it breed and suddenly we have removed this control. The virus multiplies like crazy, like an avalanche. And the person ends up with all indications of the immune system failing. It's exactly the same as a death sentence." The Ministry of Health is confident there is no threat of interrupted treatment. They say some of the drugs are currently undergoing quality control, and any missing drugs will be procured by next week. Ukraine has the biggest number of HIV-positive patients in Europe -- between 170 to 360 thousand people live with the virus. Every day, 50 Ukrainians die from diseases caused by AIDS. NTD, Kyiv, Ukraine.
Просмотров: 255 NTDTV
Pharmocracy -  The Only Solution to the Healthcare Crisis
 
02:33
This eye-opening video exposes the inefficient and corrupt reasons why medical prices have skyrocketed out of control. More important, it provides a blueprint for what citizens can do to combat the regulatory stranglehold over health care that enables the medical establishment to defraud consumers out of their health and money.
Просмотров: 341 Life Extension
16. Evolution of Tobacco Law
 
47:20
Environmental Politics and Law (EVST 255) This lecture continues the previous class's discussion of tobacco law. In this class, Professor Wargo highlights the unique issues of freedom of choice and freedom of speech that tobacco regulation create, as tobacco regulation restricts individual choice and corporate freedom of speech via advertising restrictions. Tobacco law also illustrates the difficulties of managing environmental hazards in the face of an industry with the resources to fund its own research and to fight regulation at every step of the process. The passing of the Family Smoking Prevention and Tobacco Control Act in 2009 is held up as a success story in tobacco regulation, as it places stricter standards on tobacco corporations. 00:00 - Chapter 1. Efforts on the Part of the Industry to Understand Nicotine 11:07 - Chapter 2. Tobacco Industry Challenges FDA; Various Settlements 20:24 - Chapter 3. If It's a Drug, Where's the Benefit? 25:25 - Chapter 4. Family Smoking Prevention and Tobacco Control Act 31:12 - Chapter 5. Control Programs; Mass Media; Science and Industry 37:09 - Chapter 6. Industry Arguments; Environmental and Consumer Group Arguments Complete course materials are available at the Open Yale Courses website: http://open.yale.edu/courses This course was recorded in Spring 2010.
Просмотров: 4507 YaleCourses
Testosterone and the FDA
 
16:35
Просмотров: 365 BioBalanceHealthcast
Easier to Attack the Weak than the Wealthy
 
11:00
Rob Johnson: For GOP and Dems easier to make people pay for crisis than confront big campaign funders
Просмотров: 3806 TheRealNews
Elizabeth Warren pHARMa infobomb
 
07:18
I gave Elizabeth Warren a stack of articles about fraud and harm inflicted by psychiatry.
Просмотров: 396 survivor030406
"Eavesdropping On the Chemical Conversations Between Brain Cells"
 
01:18:39
A lecture by UM Department of Biomedical and Pharmaceutical Sciences Professor Richard Bridges. This was the first event of the 2011 Community Lecture Series at The University of Montana titled "The Beauty of the Brain." The features six lectures by five outstanding UM faculty members who will examine the science and evolution of learning.
Просмотров: 619 University of Montana
Health Care Reform and Its Impact on Innovation in the Biopharmaceutical Industry (Kevin Sharer)
 
05:55
Visit USC on YouTube: http://www.youtube.com/usc Learn more about the University of Southern California: http://www.usc.edu The USC Schaeffer Center for Health Policy and Economics hosted a conference Oct. 22, 2010, titled, "Health Reform and the Economy: Are They Good for Each Other?" Conference panels examined critical reform issues related to reducing costs, improving quality, ensuring innovation and changing health care delivery. The assembly of renowned speakers from government, academia and industry presented different views -- some were concerned that health reform will not control costs, while others believed that incentives in the new health law for more robust information technology and provider payment reform will begin to bend the cost curve. In the panel titled "New Rules: Will They Chill Innovation?" panelists Darius Lakdawalla, Daniel McFadden, Kevin Sharer (presentation: "Health Care Reform and Its Impact on Innovation in the Biopharmaceutical Industry") and Micah Weinberg explored whether health reform will reduce market incentives for pharma and device makers to develop new technology due to potential impacts on profits. It was acknowledged that technology is a major cost driver but also that higher prices support innovation that benefits future patients. In addition, opportunities remain because of unmet need, an aging population, the fact that innovation is valued and global markets. Learn more about the University of Southern California: http://www.usc.edu Learn more about the USC Schaeffer Center for Health Policy and Economics: http://healthpolicy.usc.edu/
Просмотров: 249 USC
Animated Trial Exhibits: Hatch Waxman ANDA Timeline
 
00:33
For more information, refer to our blog post on timeline trial exhibits: http://www.a2lc.com/blog/bid/34757/Litigation-Graphics-Timelines-Can-Persuade-Judges-and-Juries Timelines are used in virtually every piece of litigation. The same is true for PowerPoint timelines such as this exhibit. However, just because a timeline is a routine part of a courtroom proceeding, it does not mean that the chart itself must follow the typical colored date bar down the center with text bubbles placed around it. In this timeline, the colored bars represent periods of conversation with the FDA that delayed the approval of an ANDA. This visually proves that the citizen petition did not cause a delay in the approval of the generic version drug. Rather, it was the FDA taking its time in its review. Consider all of the information (thousands of pages of documents) that are summarzed in this timeline and the fact that it helped lead to a 100% defense verdict for Animators at Law's brand name pharmaceutical client.
Просмотров: 968 AnimatorsatLaw
MEDICAL COMPANIES FINED 7 MILLION YUAN FOR MONOPOLY.
 
02:23
The National Development and Reform Commission has fined two medical companies in Eastern China's Shandong province nearly seven million yuan. The firms are accused of controlling raw materials of compound reserpine, an anti-hypertensive drug and increasing its bid prices.
Просмотров: 101 WealthOfHealth4
Export Commodity Classification
 
58:41
In this webinar you will learn from the experts from the Commodity Analysis Branch of the Census Bureau on the Harmonized System, classification tools, general rules of interpretations and the Schedule B Manual. You will also learn how to classify your products from experts who handle classification matters every day. You will learn about the Harmonized Tariff Classification System, where to find the classification search engine and how to use it. For more, visit http://export.gov/webinars/eg_main_028231.asp February 22, 2011
Просмотров: 5823 International Trade Administration
Eric Roberts visits popular Los Angeles news show to discuss Genmed
 
02:33
Eric Roberts, the new spokesman for Genmed Holding Corporation, visits the set of KCAL 9 News at Noon to discuss the company and its mission to distribute low cost generic drugs into the global market of countries in need
Просмотров: 457 scriptedconsulting
Strategic Joint Ventures & learn why your profits are being
 
02:26
http://www.miniploy.com Outsorcing To Make Money declan@leisuretime-media.comStrategic Joint Ventures & learn why your profits are being held to ransomMy aim is to increase the somewhat limited vision that some companies have to see the wealth of opportunities available to them through strategic alliances and joint ventures. The reason most companies don't do this is because of the significant costs and time involved in diverting resources to research and development new products. Most companies have established a high level of trust and credibility with their customers but rarely it to their full advantage. When a company has reached "business maturity" they are very powerful yet often underutilized assets. By that I mean having a balance of solid products and loyal customers, they have the finances to operate efficiently and effectively as well as the proper staff to carry out the daily operations. By being granted use and control of these assets a business development specialist like myself has the ability to locate and exploit profit centres that were previously untapped. You see, a mature business with a great list is actually a distribution network capable of selling dozens of additional products and services to their customers resulting in massive profits. After all, who doesn't want more profit that's so easy to come by! My experience allows me to match a variety of proven products or services to a list that will bring in massive profits for both parties.
Просмотров: 10 learnseoquick
Amylin, Alkermes Down After Bydureon Outperformed By Victoza
 
00:58
Amylin Pharmaceuticals (NASDAQ:AMLN) and Alkermes (NASDAQ:ALKS) were both sharply down Thursday after their diabetes drug Bydureon was outperformed by Novo Nordisk's drug Victoza in a head-to-head study. Bydureon lowered blood-sugar levels by an average of 1.3 percentage points, compared with 1.5 percentage points for Victoza. The drug is a weekly version of Byetta, which is injected twice daily. Victoza, approved in the U.S. in 2010, is taken once daily and generated $433 million in sales last year. Phil Nadeau, an analyst with Cowen & Co. in New York, said in a report, "We thought that Bydureon would look at least as good as Victoza, These data give Novo a very powerful marketing message to use against Bydureon when it is launched." Amylin is trading down almost 25% at $11.28 and Alkermes is trading down over 12% at $12.40 on the news.
Просмотров: 1800 FinancialNewsOnline
ORHP Small Health Care Provider Quality Improvement Program Peer Learning Workshop Pt. 2
 
46:56
In this session, updates on emerging HRSA and HHS issues and initiatives will be provided. The significance of these topics to safety-net health care proviers and frontier communities will be highlighted.
Просмотров: 1034 HRSAtube
Doctor's Wife Sues Family, Psychiatrist
 
00:41
Mary Wolf files wrongful-death lawsuit claiming others could have prevented her son's death.
Просмотров: 65 KOCO 5 News
Money Talks: Profits Before Patient Safety (full film)
 
49:23
Просмотров: 15825 HollyM
Introduction to Dictionary Skills
 
07:05
A charming introduction to first dictionary skills, to help every child understand how to use dictionaries to find the words they need, and enrich their language.
Просмотров: 264045 Oxford Education
Typical v. Novel Antipsychotic Side Effects.mp4
 
12:01
Typical v. Novel Antipsychotic Side Effects.mp4
Просмотров: 2653 vpcrashfrog
El monopolio de la gran industria farmacéutica sobre la propiedad intelectual - TPP
 
09:48
Más información en: http://medicinasparatodos.blogspot.com/ ¿Quién no se ha enfermado alguna vez en su vida? ¿Quién no ha ido a la farmacia y ha tenido que comprar sólo una parte de la receta porque no le alcanza para todo? Esta triste realidad afecta principalmente a las familias más pobres. En la actualidad, la gran industria farmacéutica pretende ampliar su monopolio sobre las patentes de los medicamentos. Esto sería peligroso para el Perú porque si la gran industria farmacéutica consigue ampliar la vigencia del derecho a las patentes o consigue nuevas patentes, uno de los efectos será el aumento de los precios de las medicinas. Es por ello, que en las negociaciones comerciales la propiedad intelectual es un asunto estratégico para la industria farmacéutica. El Perú está recibiendo las presiones de los Estados Unidos y de las industrias farmacéuticas, cuyo poder sigue avanzando de manera peligrosa ¿A quién protegerá el Estado? ¿A los monopolios de las grandes industrias farmacéuticas o a la salud de las peruanas y peruanos? Reportaje y Guión: Ricardo Marapi Cámara: Fernando Salazar Edición: Ricardo Marapi y Fernando Salazar Asistencia de Producción: Mayit Candela Video producido por REDGE y Acción Internacional para la Salud, AIS Más información en: http://medicinasparatodos.blogspot.com/
Просмотров: 18439 Cepes Rural